Purpose: To prospectively define the setup error and the interfraction prostate localization accuracy of the planning target volume (PTV) in the presence of an endorectal balloon (ERB) device. Patients and Methods: Weekly portal images (PIs) of 15 patients undergoing external-beam radiotherapy were analyzed. Displacements of the isocenter and the center of the ERB were measured. The setup and target motion variability were assessed with regard to the position variability of the ERB. Results: The setup error was random and target motion variability was largest in the craniocaudal direction. The mean displacement of the isocenter was 2.1 mm (± 1.2 mm SD [standard deviation]), 2.4 mm (± 2.2 mm SD), and 3.8 mm (± 4.0 mm SD) in the left-right, craniocaudal, and anteroposterior directions, respectively (p = 0.1). The mean displacement of the ERB was 2.0 mm (± 1.4 mm SD), 4.1 mm (± 2.0 mm SD), and 3.8 mm (± 3.3 mm SD; p = 0.03). Setup margin and internal margin contributed equally to the PTV margin. Cumulative placement insecurity of the field and the ERB together was 4.0 mm (± 2.1 mm SD) laterally, 6.4 mm (± 2.5 mm SD) craniocaudally, and 7.7 mm (± 7.0 mm SD) anteroposteriorly. The 95% CIs (confidence intervals) were 2.9-5.2 mm, 5.1-7.8 mm, and 3.8-11.5 mm. In 35% of cases, the estimation of the dorsal margin exceeded 1 cm. Conclusion: Margin estimate dorsally may exceed 1 cm and on-line position verification with an ERB cannot be recommended for dose escalation > 70 Gy. 
Introduction
On-line position verification of the prostate is a prerequisite for high-dose external-beam radiotherapy (EBRT) to the prostate. Dose escalation improves biochemical relapse-free survival and conformal radiotherapy (CRT) decreases treatment-related morbidity [5, 6, 9, 11-13, 22, 25, 26, 35] . CRT and multileaf collimators (MLCs) reduce the volume of normal tissue included in the planning target volume (PTV) by up to 40% compared to conventional radiotherapy (RT) and thus decrease the normal-tissue complication probability (NTCP) [10] . Reduced dose delivered to non-cancer tissue, however, is defined by the setup margin surrounding the cancer tissue in the clinical target volume (CTV). The PTV margin as defined by ICRU (Report No. 62) consists of two components, the internal margin (IM) reflecting anatomic position variability and the setup margin, defined by the daily positioning and machine geometry variability [16] . The IM accounts for changes in shape, size, and motion of the CTV, while the setup margin accounts for errors in positioning. One of the major problems is the interfraction motion of the prostate affected by rectal and bladder filling and contractions of the pelvic floor [7, 18, 28, 30, 33, 34] .
Interfraction motion can be reduced with positioning devices such as casts or leg holders, fixation devices such as endorectal balloons (ERBs) or spacers [3, 14, 15, 31] , by treating only patients with a full bladder (500 cm 3 of fluids), and the use of laxatives to minimize pelvic organ filling and motion of the prostate [4, 27, 29] . Direct visualization before treatment with ultrasound or pretreatment session computed tomography (CT) scans has been evaluated [17] . Gold fiducial markers implanted in the prostate may also be used to assess interfraction mobility and allow on-line prostate position verification [19] . Implantation of markers, however, is an invasive procedure and carries a small but definitive risk of complications such as septicemia, hematuria, hemospermia, and rectal bleeding [1, 33] .
In the present study, we prospectively evaluated the ability of an ERB device to reduce the posterior PTV margin and whether an ERB by itself would be suitable for dose escalation treatment without additional prostate positioning techniques.
Patients and Methods
15 patients with non-metastatic node-negative adenocarcinoma of the prostate undergoing conformal EBRT with curative intent were investigated. The patients' average age was 70.7 years (range: 65-78 years). The mean prostate-specific antigen (PSA) at presentation was 25.4 ng/l (± 25.6 ng/l SD [standard deviation]; range: 0.4-106 ng/l). Five patients each presented with stage T1c, T2, and T3 disease. The median Gleason Score was 7 (range: 5-10). All patients had CT-based treatment planning and were treated as described previously [3] . An ERB was placed in the rectum and inflated with 60 cm 3 of air, followed by RT planning (Pinnacle TM, Philips Laboratories GmbH, Düsseldorf, Germany) target delineation. Patients were treated using a four-field box technique with MLCs on a 6-MV linear accelerator (Varian 600c or 6EX, Varian Associates, Palo Alto, CA, USA). After 50 Gy, the PTV margin was reduced. 70 Gy in 2 Gy per day over 7 weeks were applied.
Portal images (PIs) were acquired using an electronic portal imaging device (EPID). The first image was acquired before delivering the first fraction and compared to the digitally reconstructed radiograph (DRR) of the corresponding field. PIs were obtained weekly [2] .
PIs were transferred with DICOM (Digital Imaging and Communication in Medicine) via a verifying system (Multi-Access, Impact Medical system, Palo Alto, CA, USA) for our analysis. To depict the center of the radiation field, a grid setup was used. The ERB outline and the center of the balloon were defined. Measurements were taken from the isocenter and a fixed bony landmark to assess setup variations. Measurements from the center of the ERB to the same bony landmarks were used to determine the interfraction target mobility. The measurements recorded from the DRR served as baseline and any deviation recorded in any of the subsequent PIs was measured.
Statistical Analysis
SDs were calculated according to the formula S 2 = Σ (X-M)/N, where X is the value of the score, M is the mean, and N is the number of scores. The 95% confidence intervals (CIs) were computed with Z = (t 0.95) × SEM (standard error of the mean). The comparison between the mean setup and target motion variation was assessed with Student's paired t-test. Setup variations, as well as organ movement in the course of RT, were calculated using a repeated measures analysis of variance test.
Results

Position of the Isocenter in Relation to the Symphysis Pubis
The mean distance between the symphysis pubis (SP) and the center of the field in the lateral direction was 3.4 mm (± 1.1 mm SD), and the median 3.7 mm (range: 1.6-6.0 mm) with a 95% CI of 2.8-4.0 mm. In the craniocaudal direction, the average distance between the upper border of the SP and the center of the field was 2.9 mm (± 0.66 mm SD), and the median 12.2 mm (range: 2.7-23.1 mm) with a 95% CI of 9.2-16.6 mm. In the anteroposterior direction, the center of the field averaged 56.3 mm (± 8.0 mm SD), with a median value of 54.0 mm (range: 44.3-70.6 mm) and a 95% CI of 51.8-60.7 mm. Results are summarized in Table 1 .
Position of the Center of the ERB in Relation to the Symphysis Pubis
As for the ERB, the mean distance between the SP and the center of the ERB in lateral direction was 2.8 mm (± 1.5 mm SD), and the median 2.9 mm (range: 0.4-5.4 mm) with a 95% CI of 2.0-3.6 mm. Craniocaudally, the mean distance between center of the ERB and the upper border of the SP was 12.0 mm Table 2 .
Assessment of Setup Variations
Mean displacement of the center of the field from its baseline position in the lateral direction was 2.1 mm (± 1.2 mm SD), with a median value of 2.1 mm (range: 0.2-4.8 mm). In the craniocaudal direction, the displacement was 2.4 mm (± 2.2 mm SD), with a median of 1.5 mm (range: 0.5-7.8 mm). In the anteroposterior direction, displacement of the field center was 3.8 mm (± 4.0 mm SD), with a median of 2.5 mm (range: 0.1-16.3 mm). There were no significant differences between the displacement of the field center in x, y, or z (p = 0.1).
Assessment of Target Mobility Variations
The mean lateral displacement of the center of the balloon was 2.0 mm (± 1.4 mm SD), with a median of 1.6 mm (range: 0.4-4.8 mm). In the craniocaudal direction, mean displacement was 4.1 mm (± 2.0 mm SD), with a median of 3.9 mm (range: 1.6-7.2 mm). Anteroposteriorly, mean displacement was 3.8 mm (± 3.3 mm SD), with a median of 2.9 mm (range: 0.4-11.7 mm). Overall differences were statistically significant (p = 0.03), especially the difference between the lateral and the craniocaudal variations (p = 0.007). No difference of the displacement variability of the center of the balloon and the center of the ERB were found, and the contributions of the setup margin and the IM to the final PTV margin were comparable ( Table 3) .
The mean and the SD of the target mobility are shown for the lateral (Figure 1a) , craniocaudal (Figure 1b) , and anteroposterior (Figure 1c) directions. Variations exceeding 10 mm were recorded in 1.7%, 12.5%, and 17% of measurements in the lateral, craniocaudal, and anteroposterior directions of motion, respectively.
Assessment of PTV Margins
Total combined displacement variability of the field and the ERB laterally was 4.0 mm (± 2.1 mm SD), with a median of 4.1 mm (range: 0.8-6.9 mm) and a 95% CI of 2.9-5.2 mm. In the craniocaudal direction, the displacement was 6.4 mm (± 2.5 mm SD), with a median of 7.0 mm (range: 2.3-9.6 mm) and a 95% CI of 5.1-7.8 mm. In the anteroposterior direction, the mean value was 7.7 mm (± 7.0 mm SD), with a median of 5.5 mm (range: 0.6-28 mm) and a 95% CI of 3.8-11.5 mm (Table 4) . PTV margins were 5.2 mm laterally, 7.8 mm craniocaudally, and 11.5 mm anteroposteriorly. The PTV margin in the anteroposterior direction exceeded 10 mm in 35% of incidences.
Discussion
Minimizing RT dose delivered to the rectal wall during curative treatment of prostate cancer is important to avoid unnecessary toxicity [20] . We and others have previously shown, that an ERB reduces prostate mobility and the dose of ionizing radiation delivered to the rectal mucosa [7, 15, 32] . We measured PTV margins in the absence of additional prostate localization techniques except an ERB. We found that internal motion and field setup variability in the presence of an ERB alone results in a suboptimal PTV margin in anteroposterior direction exceeding a positioning accuracy of 1 cm in one third of patients. Table 3 . Displacement of the center of the field and the center of the endorectal balloon (ERB) in relation to the symphysis pubis. SD: standard deviation. We accepted the ERB mobility as a surrogate for prostate mobility in this study based on our previous analysis [7] . We assumed that the position variability of the ERB represents internal target positioning variability and the interfraction mobility. Overall, IM variability was comparable to the setup variability. However, besides the inaccuracy in anteroposterior direction, the ERB seems insufficient for prostate location for the purpose of dose escalation, because the IM in craniocaudal direction exceeds the setup variability, which is consistent with our previous study [3] . The imprecision in craniocaudal direction may be substantial for cases requiring treatment of the seminal vesicles.
Several authors reported on ERB and motion variability and PTV margins. McGary et al. assessed prostate displacement in ten patients with an ERB during the course of intensity-modulated radiation treatment (IMRT) [21] . The prostate displacement in the anteroposterior and the lateral direction was shown to be in the order of ~1 mm. The SD of the craniocaudal displacements was 1.8 mm and comparable to the SD in the present study. In a comparative study by D'Amico et al., the mean displacement of the prostate with an ERB was 1.3 (0-2.2) mm compared to 1.8 (0-9.1) mm (p = 0.03) without an ERB, and the ERB reduced prostate motion variability [8] . Maximum displacement was reduced from 4 mm to ≤ 1 mm using a balloon. Wachter et al. found that maximum displacements of posterior prostate border (> 5 mm) were found in eight of ten patients without and in only two of ten patients with an ERB [32] . The balloon reduced the posterior rectal wall volume in the high-dose regions without changing exposure of the anterior half of the rectal wall. Van Lin et al. compared patients irradiated using an ERB to patients without an ERB [31] . Patients had gold markers implanted, as well, and an off-line electronic portal imaging correction protocol was used for prostate position verification; the fiducial markers were effective in reducing the systematic prostate displacements, whereas the ERB did not reduce the interfraction prostate motion. Patel et al. evaluated the volumes of the rectal wall and the bladder receiving high-dose RT in respect of presence or absence of an ERB for 3D-conformal RT, IMRT, and helical tomotherapy [23, 24] . An ERB in 3D-CRT reduced the rectal volume by 40%, 42%, and 44% at doses of 60 Gy, 65 Gy, and 70 Gy, respectively. Interestingly, helical tomotherapy resulted in the smallest volume of the rectum irradiated to a high dose when compared to 3D-CRT. Recently, van Lin et al. reported that an ERB used during dose escalation resulted in significant rectal wall sparing potentially reducing late rectal toxicity [31] . Taken together, the PTV margin anteroposteriorly do not seem to be reduced to < 1 cm by the ERB. Thus, the ERB by itself is not sufficient for elimination of interfraction motion of the prostate in respect of the area of the anterior rectal wall exposed to high-dose RT. Additional positioning techniques such as intraprostatic fiducial markers or on-line CT imaging may reduce PTV margins sufficiently for dose escalation.
